Abstract:
The Fe/C micro-electrolysis-Fenton-coagulation sedimentation-hydrolytic acidification-UASB-A/O process designed by a chemical engineering enterprise in Jiangsu Province,has been used for treating the wastewater from pharmaceutical intermittent production. The results of continuous operation show that under the following conditions:the influent flow rate is 320 m3/d,highly concentrated influent COD 15 000 mg/L,and mediumly concentrated influent COD about 1 200 mg/L,being treated by this process,the effluent COD can be stabilized at about 380 mg/L,and pH 6-9. As a result,the effluent water quality meets the third level criteria requirements specified in the Integrated Wastewater Discharge Standard(GB 8976—1996).
Key words:
wastewater from pharmaceutical intermittent production,
Fe/C micro-electrolysis,
Fenton,
coagulation sedimentation,
hydrolytic acidification,
UASB,
A/O
摘要：
江苏某化工企业设计采用铁炭微电解—Fenton—混凝沉淀—水解酸化—UASB—A/O工艺处理医药中间体生产废水。连续运行结果表明,在进水流量为320 m3/d、高浓进水COD为15 000 mg/L、中浓进水COD为 1 200 mg/L左右条件下,经过该工艺处理,出水COD稳定在380 mg/L左右,pH在6～9,出水水质达到GB 8978—1996《污水综合排放标准》的Ⅲ级标准。
关键词:
医药中间体生产废水,
铁炭微电解,
Fenton,
混凝沉淀,
水解酸化,
UASB,
A/O
CLC Number:
Zhai Jian, Jiang Chunhua, Zhang Tantan, Sun Yue, Gao Xiaojing. Case study on the treatment of wastewater from pharmaceutical intermittent production[J]. INDUSTRIAL WATER TREATMENT, 2015, 35(8): 101-103.
翟建, 姜春华, 张潭潭, 孙玥, 高晓晶. 医药中间体生产废水处理工程实例[J]. 工业水处理, 2015, 35(8): 101-103.